AKRO - Akero Therapeutics EPS beats by $0.03 November, 12 2020 04:41 PM Akero Therapeutics Inc. Akero Therapeutics (AKRO): Q3 GAAP EPS of -$0.63 beats by $0.03.Cash, cash equivalents and short-term marketable securities of $291.9M.Press Release For further details see: Akero Therapeutics EPS beats by $0.03